Epigral Ltd vs Linde India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Epigral Ltd is ₹ 853 as of 18 Mar 15:28 . The p/e ratio of Epigral Ltd changed from 11.1 to 16 over 5 quarters. This represents a CAGR of 33.98% The p/e ratio of Linde India Ltd changed from 41.9 to 0 over 6 quarters. This represents a CAGR of -100.00% The market cap of Epigral Ltd changed from ₹ 3919 crore to ₹ 4045 crore over 5 quarters. This represents a CAGR of 2.57% The market cap of Linde India Ltd changed from ₹ 21241 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Linde India Ltd for the Dec '25 is ₹ 756.23 crore as compare to the Sep '25 revenue of ₹ 649.71 crore. This represent the growth of 16.4% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Linde India Ltd for the Dec '25 is ₹ 312.06 crore as compare to the Sep '25 ebitda of ₹ 287.84 crore. This represent the growth of 8.41% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The net profit of Linde India Ltd changed from ₹ 113.69 crore to ₹ 193.33 crore over 7 quarters. This represents a CAGR of 35.44% The dividend payout of Epigral Ltd changed from 5.88 % to 0 % over 5 quarters. This represents a CAGR of -100.00% The dividend payout of Linde India Ltd changed from 22.4 % to 0 % over 6 quarters. This represents a CAGR of -100.00% .

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

About Linde India Ltd

Linde India Limited, is a member of Linde plc.
Linde owns Indias largest air separation plant and run more than 25 operating facilities across the country.
The Project Engineering Division (PED) comprises the business of designing, supply, installation and commissioning of tonnage air separation units (ASU), and projects relating to setting up of nitrogen plants, pressure swing adsorption (PSA) plants and gas distribution systems.
PED also manufactures cryogenic vessels for in-house use as well as for sale to third party customers. Linde India Limited was erstwhile incorporated on January 24, 1935 as 'Indian Oxygen and Acetylene Company Limited'.
The Company was promoted by BOC Group UK, as a private limited company.

FAQs for the comparison of Epigral Ltd and Linde India Ltd

Which company has a larger market capitalization, Epigral Ltd or Linde India Ltd?

Market cap of Epigral Ltd is 3,685 Cr while Market cap of Linde India Ltd is 62,435 Cr

What are the key factors driving the stock performance of Epigral Ltd and Linde India Ltd?

The stock performance of Epigral Ltd and Linde India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Epigral Ltd and Linde India Ltd?

As of March 18, 2026, the Epigral Ltd stock price is INR ₹854.2. On the other hand, Linde India Ltd stock price is INR ₹7321.2.

How do dividend payouts of Epigral Ltd and Linde India Ltd compare?

To compare the dividend payouts of Epigral Ltd and Linde India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.